Private Equity

With a key FDA filing and pivotal data on the horizon, Pharvaris aims to redefine HAE treatment with its convenient, rapid-acting oral therapy.

Amidst a strategic push for profitability, CytoSorbents advances its DrugSorb-ATR device, aiming to revolutionize safety in cardiac surgery.

Uniper secures 500,000 tons of certified green ammonia from India's AM Green, forging a new energy axis and fueling Europe's industrial decarbonization.

A new joint venture will build a massive solar tracker factory in Saudi Arabia, aiming to accelerate the Kingdom's green energy goals and create 2,000 jobs.

A federal court blocked Edwards Lifesciences' key acquisition, citing monopoly fears, yet the company's financial outlook surprisingly improves.

Following its acquisition by education giant Cogna, Vasta Platform is leaving the US stock market, signaling a major shift in Brazil's EdTech landscape.

In a strategic move consolidating the aviation aftermarket, AxioAero Group has acquired MRO specialist Airway Aerospace, signaling a broader industry trend.

Denver approves a $70M public investment for a new NWSL stadium, aiming to transform a vacant industrial site and cement its place in women's sports.

The Chinese auto-tech firm regained Nasdaq's minimum bid price but still faces delisting over its low market value, setting up a critical hearing.

A massive partnership aims to build gigawatt-scale data centers for OpenAI's 'Stargate' project, merging AI ambition with immense energy demands.

A new report reveals a paradoxical trend: plaintiff firms are filing fewer securities lawsuits but securing record-breaking, multi-million dollar settlements.

With final approval for its C$3.3 billion acquisition by GTCR, Dentalcorp's move to private ownership is set to reshape Canada's dental landscape.

With three international awards, Marina Pointe isn't just selling condos; it's cementing Tampa Bay's status as a premier global luxury destination.

Alto's ambitious high-speed rail plan is moving forward, with the Montréal-Ottawa line as its first phase. Public consultations are set to begin this month.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

Beyond a simple time change, Fortrea's upcoming JPM presentation is a critical test for its new CEO and a key moment to define its future in the CRO market.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A top luxury planner is trading Zoom calls for Swiss Alps adventures, letting couples "test-drive" their destination wedding before they say "I do."

ProMach's strategic purchase of AmHolt from Arcline signals a major push to dominate the packaging lifecycle, from new machines to critical aftermarket parts.

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.